Alkermes plc (ALKS) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Ireland, listed on NasdaqGS. Market cap 6.73B USD. 52-week range 27.00 to 55.67 USD. Trailing P/E 105.6. Data as of 2026-10-09.
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. ...